AML is: Evaluated with molecular tests such as flt 3 itd npm1. Most important if the bm cytogenetic s were normal. Look at the AML info at lls.Org.
Answered 6/10/2014
5.3k views
Cytogenetics: If the peripheral blood speciment is adequate for cytogenetic evaluation. Bone marrow aspirate is usually more preferable speciment for cytogenetic evaluation -especially if the peripheral blood is not adequate. I advise you to d/w your oncologist for detail discussion re- cytogenetic, prognostication etc. However, a normal cytogenetics- will put her on the intermediate risk category. See lls.Org.
Answered 2/26/2013
5.3k views
2 doctors weighed in across 2 answers
6 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question